Vyxeos 44mg/100mg Infusionsl sung 1St x 50ml (Daunorubicin and cytarabine)

Reference priceJPY ¥91,875.00Original source price: INR 52,500.00. Converted estimates are available by currency selection.

Brand	Vyxeos
Manufacturer	Jazz Pharmaceuticals plc
Prescription required	Yes

Description

Vyxeos 44mg/100mg Infusionsl sung 1St x 50ml(/) (Daunorubicin and cytarabine) is a medicine catalog record in the MediPriceHub database. Active ingredient: Daunorubicin and cytarabine. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Jazz Pharmaceuticals plc. Therapeutic category: Medicine Library > Oncology Medicines > Leukemia Medicines. Pack information: Vyxeos 44 / 100, 1 x 50. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.

Benefits

VYXEOS is indicated for the treatment of newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.

How to Use

Jazz Pharmaceuticals Ireland Ltd

Specification

Active ingredient: Daunorubicin and cytarabine. Pack size: Vyxeos 44 / 100, 1 x 50. Pack unit: bottle. Manufacturer: Jazz Pharmaceuticals plc. Origin country: Germany. Source category: Medicine Library > Oncology Medicines > Leukemia Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.

Side Effects

Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Injectable and infusion products may also cause administration-site pain, swelling, infection, infusion reactions, or hypersensitivity. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.

この情報は参考情報です。医薬品を使用する前に医療専門家へご相談ください。